Conference Coverage
Conference Coverage
Calcium scores predict sudden-death risk in preclinical CAD
The findings strengthen the case for initial CAC imaging as a gatekeeper to further testing in some primary-prevention patients, researchers say...
Conference Coverage
Hybrid ACC 2022 resurrects the live scientific session
The ACC offers a traditional in-person meeting spanning all of cardiology paired with what could be a lasting legacy of the pandemic, a robust,...
Conference Coverage
Finerenone + SGLT2 inhibitor of benefit in diabetes with CKD?
Results from FIDELITY, a prespecified analysis of data from two pivotal trials of finerenone, hints of an additive benefit with SGLT2 inhibitors...
News
Limited benefits of early gestational diabetes screening
While the study did not find significant differences in maternal or neonatal outcomes for women screened early versus at the standard 24-28 weeks...
Conference Coverage
Inadequate routine diabetes screening common in HIV
People with HIV are known to be at an increased risk of diabetes and the long-term complications of the disease.
Conference Coverage
SGLT2 inhibitor use tied to fewer atrial arrhythmias
Conference Coverage
Could an oral PCSK9 inhibitor be on the horizon?
What if the cholesterol-crushing efficacy of current PCSK9 inhibitors came in a pill instead of a syringe? That’s one possibility for a Merck...
Conference Coverage
Empagliflozin a winner in challenging arena of stabilized acute HF
Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of...
Conference Coverage
EMPEROR-Preserved findings confirmed in ‘true’ HFpEF patients
Conference Coverage
ASCEND: Aspirin shows hint of dementia protection in T2D